blindness semaglutide Ozempic Blindness: Should You Worry? TGA issues warning over GLP-1-based

Among participants, women tended to lose more weight, and people with type 2 diabetes tended to lose less

Current Research or Industry Status (2026) The scientific community is highly focused on intracellular metabolic regulators as the next frontier in longevity and obesity research

Interaction with Hormone Therapy Studies show that GLP-1 medications can work well alongside hormone replacement therapy, potentially offering complementary benefits for metabolic health and menopausal symptoms

This is all because of its high bioavailability and more consistent therapeutic profile than tablet form

The Oral Advantage Most of the high-efficacy obesity compounds semaglutide, tirzepatide, retatrutide, cagrilintide are injectables